News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Aida Pharmaceuticals, Inc. (AIDA) Affiliate Developing New Antibiotic



4/9/2008 11:40:40 AM

April 9, 2008 -- Aida Pharmaceuticals, Inc. (OTCBB: AIDA) is working on a new wide-spectrum antibiotic that was discovered by its recently acquired affiliate, the Jiangsu Institute of Microbiology Co., Ltd (JSIM). Wetimicin, which belongs to a new generation of amino-glycoside antibiotics, is in Phase I trials. Aida believes the product will have a wider market than its current antibiotic, Etimicin Sulphate. In its various forms, Etimicin Sulphate produced the majority of Aida’s $29 million of revenues in 2007. Etimicin Sulphate belongs to the same family of antibiotics as Wetimicin. More details...

Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES